NCT02353806View on ClinicalTrials.gov

Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Chronic Hypertension in Pregnancy
Interventions
DRUG

Amlodipine besylate

Pregnant and postpartum women will continue taking amlodipine besylate 5 mg for treatment of chronic hypertension as prescribed by their clinician.

Trial Locations (1)

75235

Parkland Health and Hospital System, Dallas

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT02353806 - Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation | Biotech Hunter | Biotech Hunter